JP2009530359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009530359A5 JP2009530359A5 JP2009500919A JP2009500919A JP2009530359A5 JP 2009530359 A5 JP2009530359 A5 JP 2009530359A5 JP 2009500919 A JP2009500919 A JP 2009500919A JP 2009500919 A JP2009500919 A JP 2009500919A JP 2009530359 A5 JP2009530359 A5 JP 2009530359A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- use according
- establishment
- growth
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 16
- 150000001875 compounds Chemical class 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 2
- 230000002101 lytic effect Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 201000009030 Carcinoma Diseases 0.000 claims 1
- 206010025323 Lymphomas Diseases 0.000 claims 1
- 206010039491 Sarcoma Diseases 0.000 claims 1
- 230000004721 adaptive immunity Effects 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000006037 cell lysis Effects 0.000 claims 1
- 230000009036 growth inhibition Effects 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000028993 immune response Effects 0.000 claims 1
- 230000017066 negative regulation of growth Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 208000011581 secondary neoplasm Diseases 0.000 claims 1
- 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0605685.7A GB0605685D0 (en) | 2006-03-21 | 2006-03-21 | Inhibition of tumour growth |
| PCT/GB2007/000993 WO2007107748A2 (en) | 2006-03-21 | 2007-03-21 | Inhibition of tumour growth |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009530359A JP2009530359A (ja) | 2009-08-27 |
| JP2009530359A5 true JP2009530359A5 (OSRAM) | 2010-05-06 |
Family
ID=36383910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009500919A Pending JP2009530359A (ja) | 2006-03-21 | 2007-03-21 | 腫瘍成長の阻害 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2010204A2 (OSRAM) |
| JP (1) | JP2009530359A (OSRAM) |
| CN (1) | CN101466391A (OSRAM) |
| AU (1) | AU2007228574B2 (OSRAM) |
| CA (1) | CA2646589C (OSRAM) |
| GB (1) | GB0605685D0 (OSRAM) |
| NO (1) | NO20084053L (OSRAM) |
| WO (1) | WO2007107748A2 (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0821616D0 (en) * | 2008-11-26 | 2008-12-31 | Lytix Biopharma As | Compounds |
| GB201401877D0 (en) * | 2014-02-04 | 2014-03-19 | Univ Tromsoe | Peptides |
| JP6813258B2 (ja) * | 2014-12-11 | 2021-01-13 | リティックス バイオファーマ エイエス | 化学療法の組み合わせ |
| JP6767096B2 (ja) | 2014-12-11 | 2020-10-14 | リティックス バイオファーマ エイエス | 免疫チェックポイント阻害剤の組み合わせ |
| CA2976377A1 (en) * | 2015-02-12 | 2016-08-18 | The Johns Hopkins University | Inhibition of yap for breaking tumor immune tolerance |
| GB201601868D0 (en) | 2016-02-02 | 2016-03-16 | Lytix Biopharma As | Methods |
| EP4637800A1 (en) | 2022-12-20 | 2025-10-29 | Lytix Biopharma AS | Compositions comprising an oncolytic peptide and chitosan |
| WO2024133580A1 (en) | 2022-12-20 | 2024-06-27 | Lytix Biopharma As | Medical products containing an aqueous formulation of a peptide |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861478A (en) * | 1987-07-06 | 1999-01-19 | Helix Biomedix, Inc. | Lytic peptides |
| DE3854476T2 (de) * | 1987-07-06 | 1996-04-04 | Univ Louisiana State | Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden. |
| US5773413A (en) * | 1993-06-04 | 1998-06-30 | Demeter Biotechnologies, Ltd. | Method of combating mammalian neoplasias, and lytic peptides therefor |
| IL113244A0 (en) * | 1994-04-08 | 1995-07-31 | Demeter Biotech Ltd | Method of combating mammalian neoplasia and lytic peptides therefor |
| GB9818938D0 (en) * | 1998-08-28 | 1998-10-21 | Alpharma As | Bioactive peptides |
-
2006
- 2006-03-21 GB GBGB0605685.7A patent/GB0605685D0/en not_active Ceased
-
2007
- 2007-03-21 JP JP2009500919A patent/JP2009530359A/ja active Pending
- 2007-03-21 CN CNA2007800154351A patent/CN101466391A/zh active Pending
- 2007-03-21 WO PCT/GB2007/000993 patent/WO2007107748A2/en not_active Ceased
- 2007-03-21 AU AU2007228574A patent/AU2007228574B2/en not_active Ceased
- 2007-03-21 CA CA2646589A patent/CA2646589C/en not_active Expired - Fee Related
- 2007-03-21 EP EP07732085A patent/EP2010204A2/en not_active Withdrawn
-
2008
- 2008-09-24 NO NO20084053A patent/NO20084053L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009530359A5 (OSRAM) | ||
| WO2020056198A3 (en) | Substituted benzazepine compounds, conjugates, and uses thereof | |
| JP2012500001A5 (OSRAM) | ||
| JP2017057230A5 (OSRAM) | ||
| JP2016536312A5 (OSRAM) | ||
| JP2015522573A5 (OSRAM) | ||
| SI1802650T1 (sl) | Eter in tioeter substituirani ciklosporinski derivati za zdravljenje in preventivo pred infekcijami s hepatitisom c | |
| EP4241850A3 (en) | Mdm2 inhibitors and combinations thereof | |
| WO2020115555A3 (en) | Crf1 receptor antagonist, pharmaceutical formulations and solid forms thereof for the treatment of congenital adrenal hyperplasia | |
| JP2012136541A5 (OSRAM) | ||
| AU4563101A (en) | Biodegradable immunomodulatory formulations and methods for use thereof | |
| CN109952304A (zh) | 一类抑制并降解cdk的化合物 | |
| IL308807B2 (en) | Combination therapy for treating cancer | |
| AU2003296993A1 (en) | Cyclopropyl compounds as ccr5 antagonists | |
| MX2009006877A (es) | Derivados indolicos con anillo unido en las posiciones 5,6 y metodos de uso de los mismos. | |
| WO2009025196A1 (ja) | Foxm1ペプチドおよびこれを含む薬剤 | |
| WO2009060281A3 (en) | Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties | |
| CL2004000270A1 (es) | Compuestos derivados de pirazol, sus sales de adicion acidas,trastornos de vih y virus geneticamente relacionados. hidratos, solvatos; composiciones farmaceuticas; y su uso en el tramiento de trastornos del vih y virus geneticamente relacionados. | |
| JP2016502515A5 (OSRAM) | ||
| WO2005028496A3 (en) | Vaccine for treatment and prevention of herpes simplex virus infection | |
| WO2009038026A1 (ja) | Ｃｔｌ誘導剤組成物 | |
| JP2015502926A5 (OSRAM) | ||
| JP2014050390A5 (OSRAM) | ||
| CN110382500A (zh) | 用于ido和tdo双重抑制剂的脲类化合物 | |
| JP2011529683A5 (OSRAM) |